These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Mandai M, Konishi I, Koshiyama M, Mori T, Arao S, Tashiro H, Okamura H, Nomura H, Hiai H, Fukumoto M. Cancer Res; 1994 Apr 01; 54(7):1825-30. PubMed ID: 7907945 [Abstract] [Full Text] [Related]
3. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis. Viel A, Dall'Agnese L, Canzonieri V, Sopracordevole F, Capozzi E, Carbone A, Visentin MC, Boiocchi M. Cancer Res; 1995 Jun 15; 55(12):2645-50. PubMed ID: 7780979 [Abstract] [Full Text] [Related]
4. Diagnostic and biological determinants in undifferentiated and poorly differentiated ovarian carcinomas. Canzonieri V, Viel A, Visentin MC, Perin T, Sopracordevole F, Dall'Agnese L, Scara-Belli C, Boiocchi M, Carbone A. Pathologica; 1995 Oct 15; 87(5):492-7. PubMed ID: 8868173 [Abstract] [Full Text] [Related]
5. nm23-H1 protein immunoreactivity in laryngeal carcinoma. Lee CS, Redshaw A, Boag G. Cancer; 1996 Jun 01; 77(11):2246-50. PubMed ID: 8635091 [Abstract] [Full Text] [Related]
6. Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC. Gynecol Oncol; 1996 Mar 01; 60(3):363-72. PubMed ID: 8774640 [Abstract] [Full Text] [Related]
7. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S. Croat Med J; 2003 Aug 01; 44(4):429-34. PubMed ID: 12950146 [Abstract] [Full Text] [Related]
8. Expression of antimetastatic gene nm23-H1 in epithelial ovarian cancer. Qian M, Feng Y, Xu L, Zheng S, Zhou X. Chin Med J (Engl); 1997 Feb 01; 110(2):142-4. PubMed ID: 9594287 [Abstract] [Full Text] [Related]
10. Expression of nm23-H1 in transitional cell carcinoma of the upper urinary tract. Cheng HL, Tong YC, Tzai TS, Weng CL, Ho CL, Yang WH, Lin JS, Chow NH. Oncol Rep; 2001 Feb 01; 8(1):193-6. PubMed ID: 11115597 [Abstract] [Full Text] [Related]
11. nm23 protein expression in fine-needle aspirates from breast carcinoma: inverse correlation with cytologic grading, lymph node status, and ploidy. Sauer T, Furu I, Beraki K, Jebsen PW, Ormerod E, Naess O. Cancer; 1998 Apr 25; 84(2):109-14. PubMed ID: 9570214 [Abstract] [Full Text] [Related]
12. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma. Gazzeri S, Brambilla E, Negoescu A, Thoraval D, Veron M, Moro D, Brambilla C. Lab Invest; 1996 Jan 25; 74(1):158-67. PubMed ID: 8569178 [Abstract] [Full Text] [Related]
13. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma. Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K, Oka M. Br J Cancer; 1999 Oct 25; 81(3):469-75. PubMed ID: 10507772 [Abstract] [Full Text] [Related]
14. Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Sirotkovic-Skerlev M, Krizanac S, Kapitanovic S, Husnjak K, Unusic J, Pavelic K. Exp Mol Pathol; 2005 Aug 25; 79(1):42-50. PubMed ID: 16005711 [Abstract] [Full Text] [Related]
15. NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas. Borchers H, Meyers FJ, Gumerlock PH, Stewart SL, deVere White RW. J Urol; 1996 Jun 25; 155(6):2080-4. PubMed ID: 8618340 [Abstract] [Full Text] [Related]
16. Expression of nm23-H1 in human meningioma cells. Wang SW, Yam HF, Yang L, Ng HK, Wang SL, Wu BQ, Wang ZH, Chew-Cheng SB, Chew EC. Anticancer Res; 1997 Jun 25; 17(5A):3569-73. PubMed ID: 9413204 [Abstract] [Full Text] [Related]
17. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients. Galani E, Sgouros J, Petropoulou C, Janinis J, Aravantinos G, Dionysiou-Asteriou D, Skarlos D, Gonos E. Anticancer Res; 2002 Jun 25; 22(4):2275-80. PubMed ID: 12174914 [Abstract] [Full Text] [Related]
18. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases. Lai WW, Wu MH, Yan JJ, Chen FF. Ann Thorac Surg; 1996 Nov 25; 62(5):1500-4. PubMed ID: 8893591 [Abstract] [Full Text] [Related]
19. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma. Sorak M, Arsenijević S, Lukić G, Arsenijević N, Ristić P, Pavlović S, Popović S, Baskić D. J BUON; 2007 Nov 25; 12(1):99-104. PubMed ID: 17436409 [Abstract] [Full Text] [Related]
20. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival. Döme B, Somlai B, Tímár J. Anticancer Res; 2000 Nov 25; 20(5C):3971-4. PubMed ID: 11268486 [Abstract] [Full Text] [Related] Page: [Next] [New Search]